Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter V Tassev

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|February 17, 2009
Monoclonal antibody therapies for solid tumorsDimiter V Tassev, Nai-Kong V Cheung
Oncoimmunology|July 4, 2012
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivoNai-Kong V Cheung, Hongfen Guo, Jian Hu, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|February 17, 2009
Monoclonal antibody therapies for solid tumorsDimiter V Tassev, Nai-Kong V Cheung
Oncoimmunology|July 4, 2012
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivoNai-Kong V Cheung, Hongfen Guo, Jian Hu, et al.
Pageof 1